Novel drug delivery system: a promising approach in management of schizophrenia – A review

Main Article Content

Shaikh Gulam Moin Neha Sharma Meenal Rane

Abstract

Schizophrenia is a syndromic condition which is characterized by a set of signs and symptoms like delusions. It is severe non-curable illness of the brain. If not controlled and treated properly, it can lead to severe consequences. One can control these delusions by means of treatment, by using Conventional therapy or Novel therapy. There are various advantages of Novel system over Conventional system. This review focuses on understanding Novel system and its advantages over Conventional system.

Article Details

How to Cite
MOIN, Shaikh Gulam; SHARMA, Neha; RANE, Meenal. Novel drug delivery system: a promising approach in management of schizophrenia – A review. Journal of Applied Pharmaceutical Research, [S.l.], v. 5, n. 4, p. 01-04, dec. 2017. ISSN 2348-0335. Available at: <https://japtronline.com/index.php/JOAPR/article/view/124>. Date accessed: 14 aug. 2018. doi: https://doi.org/10.18231/2348-0335.2017.0007.
Section
Articles

References

[1] van Os J, Kapur S. Schizophrenia. Lancet, 374, 635–45 (2009).
[2] Dobbs D. Schizophrenia: The making of a troubled mind. Nature, 468, 154–6 (2010).
[3] Siever LJ, Davis KL. The Pathophysiology of Schizophrenia Disorders: Perspectives from the Spectrum, 2004.
[4] Sevos J, Grosselin A, Pellet J, Massoubre C, Brouillet D. Grasping the world: object-affordance effect in schizophrenia. Schizophr. Res. Treatment, 2013, 531938 (2013).
[5] Singh AN, Barlas C, Saeedi H, Mishra RK. Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia. J. Psychiatry Neurosci., 28, 39–47 (2003).
[6] Bheemidi VS, Tiruckovela M, Chettipalli ND, Yanamadala SV. Novel applications of nanotechnology in life sciences, 2011.
[7] Allen TM. Drug Delivery Systems: Entering the Mainstream. Science (80-. )., 303, 1818–22 (2004).
[8] Azarmi S, Roa W, Löbenberg R. Current perspectives in dissolution testing of conventional and novel dosage forms, 2007.
[9] Bhagwat RR, Vaidhya IS. Novel drug delivery system: An overview. Int. J. Pharm. Sci. Res., 4, 970–82 (2013).
[10] Deogade UM, Deshmukh VN, Sakarkar DM. Natural gums and mucilage’s in NDDS: Applications and recent approaches. Int. J. PharmTech Res., 4, 799–814 (2012).
[11] Rangasamy M, Parthiban KG. Recent advances in novel drug delivery systems. Int. J. Res. Ayurveda Pharm., 1, 316–26 (2010).
[12] Rasool Hassan BA. Overview on Pharmaceutical Formulation and Drug Design. Pharm. Anal. Acta, 3, (2012).
[13] Kim JS. Liposomal drug delivery system, 2016.
[14] Loucks RG, Reed RM, Ruppel SC, Hammes U. Spectrum of pore types and networks in mudrocks and a descriptive classification for matrix-related mudrock pores. Am. Assoc. Pet. Geol. Bull., 96, 1071–98 (2012).
[15] Nikalje AP. Nanotechnology and its Applications in Medicine. Med. Chem. (Los. Angeles)., 5, (2015).
[16] Venturini M, Mazzitelli S, Mičetić I, Benini C, Fabbri J, Pozzi Mucelli S, Benetti F, Nastruzzi C. Analysis of Operating Conditions Influencing the Morphology and In vitro Behaviour of Chitosan Coated Liposomes. J. Nanomed. Nanotechnol., 5, (2014).
[17] Maurer N, Fenske DB, Cullis PR. Developments in liposomal drug delivery systems. Expert Opin. Biol. Ther., 1, 923–47 (2001).
[18] Sampath KP, Bhowmik D, Srivastava S, Paswan S, Dutta AS. Sustained Release Drug Delivery System Potential. Pharma Innov., 1, 48–60 (2012).
[19] Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev., 53, 283–318 (2001).
[20] Sung H. Nanoparticles for protein drug delivery. US Pat. 7,863,258, (2011).
[21] Dwarakanadha Reddy P, Swarnalatha D. Recent advances in novel drug delivery systems. Int. J. PharmTech Res., 2, 2025–7 (2010).
[22] Allen TM, Moase EH. Therapeutic opportunities for targeted liposomal drug delivery, 1996.
[23] Esposito E. Production, Physico-Chemical Characterization and Biodistribution Studies of Lipid Nanoparticles. J. Nanomed. Nanotechnol., 6, (2015).
[24] Gao W, Hu C-MJ, Fang RH, Zhang L. Liposome-like nanostructures for drug delivery. J. Mater. Chem. B, 1, 6569 (2013).
[25] Rane S, Prabhakar B. Influence of liposome composition on paclitaxel entrapment and pH sensitivity of liposomes. Int. J. PharmTech Res., 1, 914–7 (2009).

Most read articles by the same author(s)